2026
On May 9, the Engelberg Center for Health Care Reform convened an expert workshop “Innovative Technologies and Nonprescription Medications: Addressing Undertreated Diseases and Conditions through Technology Enabled Self-Care.”
Recognizing the public health impact of undertreatment of common diseases and conditions, the U.S. Food and Drug Administration is exploring how a regulatory expansion of the nonprescription drug class might increase access to important medications and treatments. This initiative is referred to as Nonprescription Safe Use Regulatory Expansion (NSURE).
At this meeting, a wide range of experts and stakeholders explored the use of technologies as a condition to the safe use of medications within a nonprescription setting, discussed perspectives on the role of technology to support the safe and effective use of nonprescription products, and explored the integration of innovative technologies into the health care delivery system.
This expert workshop was the second in a series of meetings that will explore the NSURE initiative. To explore previous discussion regarding the potential role of health care professionals as a condition of safe use within the NSURE paradigm, please visit our expert workshop, “Nonprescription Medications with Conditions of Safe Use as a Novel Solution for Undertreated Diseases or Conditions”
Agenda
-
May 9
-
Opening Remarks
RSRachel Sherman Principal, Drug and Biological Drug Products - Greenleaf Health LLC -
Role of Technology in Facilitating the Safe and Effective Use of Nonprescription Drugs
RWSR. William Soller Executive Director and Health Sciences Clinical Professor of Pharmacy - Center for Consumer Self Care and University of California, San Francisco -
Session I: Using Innovative Technologies as a Condition of Safe Use
DSDavid Schifkovitz Vice President, Regulatory Affairs, Wellness Category and North America - GlaxoSmithKline Consumer HealthcareEOErin Oliver Director, Regulatory Affairs - GlaxoSmithKline Consumer HealthcareLRLannie Richardson Chief Executive Officer - Central Control, Inc.MGMalay Gandhi Chief Strategy Officer - Rock HealthDRDonald Reitberg Vice President - Farmacia Electronica, Inc. -
Session II: Perspectives on the Role of Technologies as a Condition of Safe Use
JAJulie AkerEHEdwin Hemwall Vice President - Global R&D, Rx-to-OTC Switch and New Opportunity Evaluation, Merck Consumer CareEBEric BrassMGMark Gelbert Senior Vice President, Global R&D and Switch - Pfizer Consumer HealthcareDPDoris Peter Director, Health Ratings Center - Consumer Health Choices -
Session III: Integrating Technologies as a Condition of Safe Use into Nonprescription Health Care Delivery Systems
JOJames Owen Associate Vice President, Practice and Science Affairs - American Pharmacists AssociationSSShelly Spiro Executive Director - Pharmacy e-Health Information Technology CollaborativeEFEdward Fotsch Chief Executive Officer - PDR NetworkDLDan Luce National Director, Pharmacy Affairs - Walgreens
-